[CLDX] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
26-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 8.46%
YoY- -11.11%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 668 236 2,728 887 546 715 1,425 -39.57%
PBT -14,224 -11,259 -12,625 -10,447 -11,413 -11,779 -17,239 -11.99%
Tax 1,088 -228 -16 -4,448 -5,090 -2,990 5,234 -64.80%
NP -14,224 -11,031 -12,625 -10,447 -11,413 -11,779 -17,239 -11.99%
Tax Rate - - - - - - - -
Total Cost 14,892 11,267 15,353 11,334 11,959 12,494 18,664 -13.93%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -2,129.34 -4,674.15 -462.79 -1,177.79 -2,090.29 -1,647.41 -1,209.75 45.63%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -0.36 -0.50 -0.73 -0.64 -0.75 -0.84 -1.40 -59.46%
EPS Diluted -0.36 -0.50 -0.73 -0.64 -0.75 -0.84 -1.40 -59.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.